PROTHENA CORP PLC (PRTA:NASDAQ)
$8.26 0 (0%)
Analysed PROTHENA CORP PLC (PRTA:NASDAQ) News Sources
AZN Posts Data From Hypophosphatasia Program on Efzimfotase Alfa
01-04-2026
yahoo.com
Prothena Announces Leadership Team Updates
10-04-2026
yahoo.com
Prothena Announces Novo Nordisk Obtains Fast Track Designation from the U.S. FDA for Coramitug (PRX004) in ATTR Amyloidosis with Cardiomyopathy
27-04-2026
yahoo.com
3 Growth Companies Insiders Are Eager To Hold
29-04-2026
yahoo.com
Stock Market Today, April 29: KalVista Pharmaceuticals Surges on Chiesi Group Acquisition Announcement
29-04-2026
fool.com
Prothena to Report First Quarter 2026 Financial Results on May 7
30-04-2026
yahoo.com
Prothena Reports First Quarter 2026 Financial Results and Business Highlights
07-05-2026
yahoo.com
Earnings Beat: Prothena Corporation plc Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
11-05-2026
yahoo.com
High Insider Ownership Growth Stocks To Watch In May 2026
28-05-2026
yahoo.com
Adaptive Biotechnologies (ADPT) Moves 9.7% Higher: Will This Strength Last?
12-06-2026
yahoo.com
What is the current price of PROTHENA CORP PLC (PRTA:NASDAQ)?
The current price of PROTHENA CORP PLC (PRTA:NASDAQ) is $8.26.
PROTHENA CORP PLC (PRTA:NASDAQ) absolute price change since previous trading day?
The absolute price change of PROTHENA CORP PLC (PRTA:NASDAQ) since the previous trading day is $0.
PROTHENA CORP PLC (PRTA:NASDAQ) percentage price change since previous trading day?
The percentage price change of PROTHENA CORP PLC (PRTA:NASDAQ) since the previous trading day is 0%.
What is the most recent average sentiment score for PROTHENA CORP PLC (PRTA:NASDAQ)?
The most recent average sentiment score for PROTHENA CORP PLC (PRTA:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for PROTHENA CORP PLC (PRTA:NASDAQ)?
The most recent sentiment for PROTHENA CORP PLC (PRTA:NASDAQ) is .
SEC-8K** Filing Available For PROTHENA CORP PLC (PRTA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.